HSE have published their latest bulletins:
REACH
- Public consultation on alternatives: call for comments
Deadline: 29 January 2024
HSE has received an application for authorisation for the following substance/use:
- Reference: AFA047-01
Applicant: Tyco Electronics
Application type: Review report
Substance: Chromium Trioxide (includes “Acids generated from chromium trioxide and their oligomers”, when used in aqueous solutions).
Use: Industrial use of chromium trioxide in conversion coating and passivation of circular and rectangular connectors in order to meet the requirements of international standards and special requirements of industries subject to harsh environments.
HSE has announced a public consultation for this application. View the details.
Article 64 in the UK REACH Regulation makes provisions for HSE to obtain and use additional information on possible alternatives or technologies as part of the opinion forming process. Any third parties with an interest in the application are strongly encouraged to share any relevant information.
Scientific and technical information on possible alternatives or technologies should be submitted directly to HSE using the commenting webform and templates by 29 January 2024.
Non-confidential comments will be published on HSE’s website. Details of the adopted opinions, granted UK REACH authorisations and in-progress applications can be found on the HSE website.
- Reference: AFA047-01
Biocides
- EU active substance open invitation deadline
Submit a notification by the deadline to keep active substances in the EU Review Programme
The European Chemicals Agency (ECHA) has published an open invitation to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations. This affects NI.
Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadline:
- Chlorine dioxide generated from Tetrachlorodecaoxide complex (TCDO) by acidification (CAS n/a EC n/a) in product types 02 and 04 (20 October 2024)
If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to EU non-approval decisions.
Biocidal products and treated articles containing active substances with EU non-approval decisions for the relevant product types will have to be removed from the NI market. HSE will provide separate updates on these where relevant.
If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.
- Active substances no longer supported in the EU
Non-approval decisions to be taken for unsupported active substances in the EU
Following an opportunity for any person, company or task force/consortium to support some of the active substance/product type combinations listed below in the EU Review Programme, no compliant notifications, or where relevant, dossiers were received. For others, the role of participant had previously been taken over and the Commission is to take non-approval decisions.
This affects NI:
- Silver-polyethylenimine-chloride (CAS n/a EC n/a) in product types 01, 02 and 09
- Garlic, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Allium sativum, Liliaceae (CAS 8008-99-9 EC 232-371-1) in product type 19
- Biphenyl-2-ol (CAS 90-43-7 EC 201-993-5) in product type 07
- Reaction products of: glutamic acid and N-(C12-C14- alkyl)propylenediamine (Glucoprotamin) (CAS 164907-72-6 EC 403-950-8) in product types 02 and 04
- Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.- hydroxy-, propanoate (salt) (“Bardap 26”)’ other than Reaction mass of N,N-didecyl-N-(2-hydroxyethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-hydroxyethoxy)ethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-N-methylammonium propionate (CAS 94667-33-1 EC n/a) in product types 02, 04 and 10
- Brandy (CAS n/a EC n/a) in product type 19
- 2,2-dibromo-2-cyanoacetamide (DBNPA) (CAS 10222-01-2 EC 233-539-7) in product type 02
- Active chlorine generated from magnesium chloride hexahydrate and potassium chloride by electrolysis (CAS 7782-50-5 EC n/a) in product type 02
These active substance/product type combinations will now be subject to an EU non-approval decision.
Once a decision is taken, biocidal products and treated articles containing these active substances in the relevant product types will have to be removed from the NI market. HSE will provide separate updates on the decision and relevant phase-out periods. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.
